This site is currently not optimized for mobile devices. For the best user experience, please access the site via a device with a wider screen such as a desktop or laptop.

For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Once enabled, click here to view the site.

signup link button why should I sign up?
Login as Volunteer Login as Study team member
OR

Studies you may be eligible for. 8

Based on the information you provided, we found the following studies.

  • Ph 2a Randomized, Open-label Study to Assess Safety/ Tolerability/Efficacy of BAX69 in Combination with 5-FU/Leucovorin or Panitumumab vs Standard of Care in Subjects with Metastatic Colorectal Cancer Part 2 study purpose: compare safety and effectiveness of study drug BAX69, when used with other drugs (standard treatment) approved to treat metastatic colorectal cancer; find out the best dose of BAX69 to use for subjects with metastatic colorectal cancer. This study is researching all of the following topics: Colorectal / Colon / Rectal cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A First-In-Human Study of Dosing with REGN2810 as Single Therapy and in Combination with Other Anti-Cancer Therapies in Patients with Advanced Malignancies Study purpose: find safe dose of REGN2810 given alone or in combination therapies;measure levels of REGN2810 in blood; evaluate if REGN2810 given alone or in combination w/other therapies will cause tumor shrinkage;test different dose levels of REGN2810, radiotherapy, GM-CSF, and cyclophosphamide. This study is researching all of the following topics: Bladder cancer Breast cancer Cervical cancer Colorectal / Colon / Rectal cancer Esophagus cancer HCC, Liver cancer Kidney Cancer ( Malignant tumor of kidney ) Laryngeal cancer, Cancer of the larynx, Voice box cancer Lung cancer Oral / Mouth cancer Ovarian cancer Pancreatic cancer Prostate cancer Stomach cancer, Gastric cancer ( Malignant tumor of stomach ) Thyroid cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Open-Label Phase 2 Study of Entrectinib (RXDX-101-02) for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors that Harbor NTRK1/2/3, ROS1, or ALK Gene Rearrangements This study will evaluate the safety (side effects) and antitumor activity of entrectinib in subjects with advanced cancer, based on certain types of DNA defect or damage. This study is researching all of the following topics: Colon Cancer ( Malignant tumor of colon ) Colorectal / Colon / Rectal cancer Lung cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Phase II study of ponatinib for advanced cancers with genomic alterations in fibroblastic growth factor receptor (FGFR) and other genomic targets (KIT, PDGFRa, RET FLT3, ABL1) The purpose of this study is to find out what effects; good and/or bad, ponatinib has on you and your cancer. Your body has proteins that are involved in a cancer’s ability to grow and survive. The drug, Ponatinib, may prevent these proteins from causing cancer growth. This study is researching all of the following topics: Bladder cancer Breast cancer Colon Cancer ( Malignant tumor of colon ) Colorectal / Colon / Rectal cancer Esophagus cancer Kidney Cancer ( Malignant tumor of kidney ) Lung cancer Ovarian cancer Pancreatic cancer Prostate cancer Thyroid cancer Uterine / Uterus cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Aquamin and Prevention of Colon Cancer The purpose of this study is to see what effects a calcium-rich, multi-mineral-rich natural product, Aquamin®, derived from marine algae, has on colon cell lining and gut microbiome, as compared to calcium alone or a sugar pill (placebo). This study is researching all of the following topics: Colorectal / Colon / Rectal cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • 18 years to 80 years
  • A Phase 1, Open-label, Dose Escalation, Safety and Tolerability Study of Investigational Drug INCB054828 in Subjects with Advanced Malignancies Study goals: determine dose that is safe and tolerable in people with advanced cancer and select the doses that will be studied further; see how INCB054828 acts on and in the body; see effect INCB054828 has on the growth of your cancer; see action of INCB054828 in the body over a period of time This study is researching all of the following topics: Bladder cancer Cervical cancer Colon Cancer ( Malignant tumor of colon ) Colorectal / Colon / Rectal cancer Kidney Cancer ( Malignant tumor of kidney ) Lung cancer Multiple myeloma Prostate cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase III Clinical Trial Evaluating TheraSphere in Patients with Metastatic Colorectal Carcinoma of the Liver who have Failed First Line Chemotherapy Study purpose: see if adding TheraSphere treatment early in current standard for second-line chemotherapy treatment of metastatic colorectal cancer is better than current treatment alone; slowing or stopping growth of liver tumors without significant increase in number or severity of side effects. This study is researching all of the following topics: Colorectal / Colon / Rectal cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase I, open-label, dose escalation study of oral LGK974 in patients with malignancies dependent on Wnt ligands This research study is to find out if the study drug LGK974 is safe and has beneficial effects in people who have pancreatic adenocarcinoma, B-RAF mutant colorectal cancer, or tumors of other origin with specific genetic changes (also called mutations) upstream in the WNT signaling pathway. This study is researching all of the following topics: Colorectal / Colon / Rectal cancer Pancreatic cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old